OncologyTube Professional - Patients Click Here
AnnualMeeting-SITC2017
19,429 video views
Loading........
Description: Stephen J. Russell, MD, PhD of Mayo Clinic discusses how viral therapy results will trigger a race to complete clinical trials. He states that there has been an increase in clinical trials due to vira...
00:25
Stephen J. Russell, MD, PhD of Mayo Clinic discusses how viral therapy results will trigger a race to complete clinical trials. He states that there has been an increase in clinical trials due to viral therapy emerging as an important combination therapy in immunotherapy. This was recorded at the AS...
by:AnnualMeeting-SITC2017 | 945 views
00:20
Stephen J. Russell, MD, PhD of Mayo Clinic explains why viral therapy may prove to be a transformationa​l addition to immuno-oncology. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
by:AnnualMeeting-SITC2017 | 1369 views
00:33
Stephen J. Russell, MD, PhD of Mayo Clinic explains why recombinant measles and recombinant vesicular stomatitis virus are ideal adjunct to checkpoint immunotherapy. Both have shown impressive activity in pre-clinical models and clinical studies. This was recorded at the ASCO-SITC Clinical Immuno-On...
by:AnnualMeeting-SITC2017 | 332 views
00:35
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute discusses how stress reducing beta blockers combined with immunotherapy may increase response rates in cancer patients. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
by:AnnualMeeting-SITC2017 | 467 views
00:40
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute explains how patients on beta blockers may do better with immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
by:AnnualMeeting-SITC2017 | 306 views
01:07
Elizabeth A. Repasky, PhD of Roswell Park Cancer Institute gives an overview of her presentation that was presented at ASCO-SITC Symposium. Her presentation focused on mild stress in mouse models, specifically thermal stress, which mirrors stress in humans. This was recorded at the ASCO-SITC Clinica...
by:AnnualMeeting-SITC2017 | 532 views
01:53
Graham P. Pawelec, PhD of Universit├Ątskli​nikum T├╝bingen explains how new data suggests immunosenescenc​e may not be a factor in immunotherapy treatment. Immunosenescenc​e suggests that older people have an immune system that does not work quite as well as the immune system in younger people. He states...
by:AnnualMeeting-SITC2017 | 663 views
01:06
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the importance of combination strategies in treatment for negative breast cancer. Specifically, in a study that combines pembrolizumab and radiation, it shows great promise for the future of combination therapy in breast cancer. This was ...
by:AnnualMeeting-SITC2017 | 1344 views
00:34
Heather McArthur, MD of Cedars-Sinai Medical Center discusses the most interesting research she has seen at the ASCO-SITC Symposium. This presentation explained the effects of a microbiome as a predictor of response to checkpoint blockade strategies. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
by:AnnualMeeting-SITC2017 | 695 views
02:07
Heather McArthur, MD of Cedars-Sinai Medical Center gives an overview of a poster discussion that was presented at the ASCO-SITC Symposium. This discussion described the results of a randomized study where docetaxel is used with or without plinabulin for patients with non-small cell lung cancer. Thi...
by:AnnualMeeting-SITC2017 | 757 views

About AnnualMeeting-SITC2017


Links
Channel Url: